Pulmonary colloid adenocarcinoma: Clinical pathological analysis of 4 cases and review of literature

Abstract

Abstract:

Objective:To investigate the clinicopathological features, immunophenotype, molecular characteristics and differential diagnosis of colloid adenocarcinoma.Methods:The clinical and pathological data of 4 cases of pulmonary adenocarcinoma were retrospectively analyzed, and associated literature was reviewed.Results:All 4 patients were elderly men, aged 61-67 years, with a median age of 64 years. Three of them had a history of smoking. The clinical manifestations were non-specific symptoms such as fatigue and cough, or without symptoms. The tumors were located in right upper lobe in 3 cases and right lower lobe in 1 case; 3 cases were peripheral located and 1 case almost occupied the entire lobe. The maximum diameter was 1.6-12.0 cm. The cut surface was grayish white, jelly-like and shiny. Microscopically, the tumor showed abundant mucin pools which destroyed the walls of alveolar spaces. The tumor cells showed goblet or signet-ring morphology, with moderate nuclear atypia and low mitotic rate, presenting singly, in small clusters or micropapillary clusters. Tumor cells floated in the mucin pool and a small number of tumor cells might line the alveolar space. Psammoma bodies could be seen in 2 cases. Immunophenotyping showed that 4 cases expressed CK7 and MUC-1, 1 case expressed CK20, 3 cases expressed TTF-1 and NapsinA（1 diffuse and 2 focal）, 2 cases expressed CDX-2, MUC-2 and Villin, 3 cases expressed MUC5AC. Molecular detection showedKRASmutation in one case.Conclusions:Pulmonary adenocarcinoma is rarely seen. The pathological diagnosis depends on histopathological examination and immunohistochemical staining. The differential diagnosis includes primary mucinous tumor of lung and metastatic mucinous adenocarcinoma. Most cases of pulmonary adenocarcinoma have a good prognosis, but the presence of non-colloid component, interstitial infiltration and micropapillary structure suggests a worse prognosis.

Key words:Lung,Colloid adenocarcinoma,Micropapillary,Psammoma body

CLC Number:

R734.2

XU Haimin, CHEN Xiaoyan, ZHANG Jing, WANG Chaofu. Pulmonary colloid adenocarcinoma: Clinical pathological analysis of 4 cases and review of literature[J]. Journal of Diagnostics Concepts & Practice, 2019, 18(06): 649-654.

Figures/Tables8

病例	性别	年龄（岁）	吸烟史	症状	体积（cm）	PET/CT	部位	手术方式	病理分期	随访
1	男	61	无	体检发现,无症状	1.6×1.6 ×1.5	代谢轻度增高	右肺上叶	肺段切除+纵隔淋巴结清除	ⅢA （T_1bN₂M₀）	术后34个月无复发及远处转移
2	男	67	有	咳嗽、咳痰,胸闷、气促	2.9×1.7 ×1.5	未查	右肺下叶	肺叶切除+纵隔淋巴结清除	ⅠA3 （T_1cN₀M₀）	术后半年发生骨转移及脑转移
3	男	66	有	体检发现,无症状	1.6×1.0 ×1.0	未查	右肺上叶	肺叶切除+纵隔淋巴结清除	ⅠA2 （T₁bN₀M₀）	术后31个月无复发转移
4	男	62	有	全身乏力半年余	12.0×11.0 ×8.0	代谢轻度增高	右肺上叶	肺叶切除+纵隔淋巴结清除	ⅢA （T₄N₀M₀）	术后半年因肺部感染、呼吸衰竭死亡

病例	TTF-1	NapsinA	SP-A	CK7	CK20	CDX-2	Villin	MUC-1	MUC-2	MUC5AC
1	-	-	-	+	-	-	-	F+	-	F+
2	F+	F+	-	+	-	+	F+	+	F+	+
3	+	+	-	+	-	-	-	+	-	+
4	F+	F+	F+	+	+	+	F+	F+	+	-

References19

[1]	Travis WD, Brambilla E, Burke AP, et al. WHO Classification oftumours of the lung, pleura, thymus and heart[M]. Lyon: IARC Press, 2015:40-41.
[2]	Zenali MJ, Weissferdt A, Solis LM, et al. An update on clinicopathological, immunohistochemical, and molecular profiles of colloid carcinoma of the lung[J]. Hum Pathol, 2015, 46(6): 836-842. doi:10.1016/j.humpath.2014.10.032 URL
[3]	Sonzogni A, Bianchi F, Fabbri A, et al. Pulmonary adenocarcinoma with mucin production modulates phenotype according to common genetic traits: a reappraisal of mucinous adenocarcinoma and colloid adenocarcinoma[J]. J Pathol Clin Res, 2017, 3(2):139-152. doi:10.1002/cjp2.67 URL
[4]	Cha YJ, Shim HS, Han J, et al. Clinicopathologic ana-lysis of 10 cases of pulmonary colloid adenocarcinoma and prognostic implication of invasive micropapillary component[J]. Pathol Res Pract, 2018, 214(12):2093-2098. doi:10.1016/j.prp.2018.10.014 URL
[5]	Masai K, Sakurai H, Suzuki S, et al. Clinicopathological features of colloid adenocarcinoma of the lung: A report of six cases[J]. JSurg Oncol, 2016, 114(2):211-215.
[6]	Rossi G, Murer B, Cavazza A, et al. Primary mucinous (so-called colloid) carcinomas of the lung: a clinicopathologic and immunohistochemical study with special refe-rence to CDX-2 homeobox gene and MUC2 expression[J]. Am J Surg Pathol, 2004, 28(4):442-452. doi:10.1097/00000478-200404000-00003 URL
[7]	Graeme-Cook F, Mark EJ. Pulmonary mucinous cystic tumors of borderline malignancy[J]. Hum Pathol, 1991, 22(2):185-190. pmid:2001880
[8]	Moran CA, Hochholzer L, Fishback N, et al. Mucinous (so-called colloid) carcinomas of lung[J]. Mod Pathol, 1992, 5(6): 634-638.
[9]	Gao ZH, Urbanski S J. The spectrum of pulmonary mu-cinous cystic neoplasia : a clinicopathologic and immunohistochemical study of ten cases and review of litera-ture[J]. Am J Clin Pathol, 2005, 124(1):62-70. doi:10.1309/52XXR6E6U0J2JX0F URL
[10]	Berger K L, Nicholson S A, Dehdashti F, et al. FDG PET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features[J]. Am J Roentgenol, 2000, 174(4):1005-1008. pmid:10749239
[11]	Shim S S, Han J. FDG-PET/CT imaging in assessing mucin-producing non-small cell lung cancer with pathologic correlation[J]. Ann Nucl Med, 2010, 24(5):357-362. doi:10.1007/s12149-010-0358-x URL
[12]	Miyake A, Okudela K, Matsumura M, et al. Update on the potential significance of psammoma bodies in lung adenocarcinoma from a modern perspective[J]. Histopatho-logy, 2018, 72(4):609-618.
[13]	Chang JC, Montecalvo J, Borsu L, et al. Bronchiolar adenoma: expansion of the concept of ciliated mucono-dular papillary tumors with proposal for revised terminology based on morphologic, immunophenotypic, and genomic analysis of 25 cases[J]. Am J Surg Pathol, 2018, 42(8):1010-1026. doi:10.1097/PAS.0000000000001086 URL
[14]	Chuang H W, Liao J B, Chang H C, et al. Ciliated muconodular papillary tumor of the lung: a newly defined peripheral pulmonary tumor with conspicuous mucin pool mimicking colloid adenocarcinoma: a case report and review of literature[J]. Pathol Int, 2014, 64(7):352-357. doi:10.1111/pin.12179 URL
[15]	陈晓炎, 杨晓群, 袁菲, 等. 肺纤毛黏液结节性乳头状肿瘤2例临床病理分析及文献复习[J]. 诊断学理论与实践, 2018, 17(5):575-580.
[16]	Ye J, Findeis-Hosey JJ, Yang Q, et al. Combination of napsin A and TTF-1 immunohistochemistry helps in differentiating primary lung adenocarcinoma from metastatic carcinoma in the lung[J]. Appl Immunohistochem Mol Morphol, 2011, 19(4):313-317. doi:10.1097/PAI.0b013e318205b059 URL
[17]	Rossi G, Cavazza A, Righi L, et al. Napsin-A, TTF-1, EGFR, and ALK status determination in lung primary and metastatic mucin-producing adenocarcinomas[J]. Int J Surg Pathol, 2014, 22(5):401-407. doi:10.1177/1066896914527609 URL
[18]	Kalhor N. Colloid carcinoma of the lung: Current views[J]. Semin Diagn Pathol, 2014, 31(4):265-270. doi:10.1053/j.semdp.2014.06.003pmid:25239272
[19]	Morita K, Nagashima A, Takemoto N, et al. Primary pulmonary mucinous (colloid) adenocarcinoma with postope-rative bone metastasis[J]. Ann Thorac Cardiovas Surg, 2014, 20(Suppl):677-681.